Oncolys BioPharma ^Investors

Oncolys BioPharma is a biopharmaceutical company that focuses on developing breakthrough therapy and diagnostics in cancer treatment. They operate in two business segments: pharmaceuticals and diagnostic reagents. Their main pipeline includes drugs for HIV infection, oncolytic virus, epigenetic anticancer drugs, and viruses for cancer and inflammatory disease detection. Oncolys BioPharma's main goal is to help patients and physicians by developing effective and innovative drugs for cancer treatment, including early detection, loco-regional therapy, prognostic tests, and systemic treatments.